|
Showing 1 - 1 of
1 matches in All Departments
The first gene responsible for Crohn's disease has now been
identified and the pathophysiological understanding of inflammatory
bowel disease as well as its practical treatment have made much
progress in recent years. Thus it is obviously important to
consider the targets and the aims of treatment in context. The Falk
Symposium No. 131 (Part II of the Gastroenterology Week Freiburg
2002), held in October 2002 in Freiburg, Germany, in its first part
was dedicated to newly defined and partly alternative therapeutic
targets. In addition, an attempt was made to learn from experts
from other fields such as pneumology or dermatology. The second
part was dedicated to the aims of treatment in daily practice.
Aside from general treatment, aims such as amelioration of
symptoms, pre-conditions of treatment, the view of the patients,
and aspects of life quality were dealt with. This volume is the
proceedings of the symposium and is important reading for both
clinicians and basic scientists.
|
You may like...
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.